retatrutide phase 2 trial results demonstrate benefits of in obesity, type 2 diabetes, NASH retatrutide triple agonist glp-1 gip

Am.J Kidney Dis 2008;52(5):962-971

good paired with fasted cardio Post-workout: Supports muscle recovery and growth Timing tips: Inject on an empty stomach or at least 2 hours after eating Wait 20-30 minutes before eating after injection Space multiple daily doses 6-8 hours apart Be consistent with timing for best results Cycle length Typical cycles: Short cycle: 8-12 weeks Standard cycle: 12-16 weeks Extended cycle: Up to 6 months (with medical supervision) Between cycles: Some users take 4-8 week breaks Others cycle continuously at lower doses No strict PCT (post-cycle therapy) required Ipamorelin doesn't suppress natural GH production Reconstitution Ipamorelin typically comes as a lyophilized (freeze-dried) powder requiring reconstitution

In the phase 2 trial, 41% to 63% of participants receiving cagrilintide (0.3 to 4.5 mg) experienced gastrointestinal adverse events, compared to 32% with placebo

Pen Dosage Chart Dosage & Protocols Variations Standard Research Protocol Dose: 0.1 0.15 mg (variant 5 mg pen = 46 clicks / variant 10 mg pen = 23 clicks) Duration: 8 12 weeks Frequency: 2 3 daily (pre-meal or pre-sleep) Cycle Interval: 4 weeks off before repeating Goal / Description: Baseline GH stimulation and appetite signaling research